The Patent Finder

Antigen Binding Molecules That Bind LIGHT

Capella Bioscience Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,227,580Antigen Binding Molecules That Bind LIGHT
In force
 · High confidence
Centessa Pharmaceuticals (UK) LimitedIn force
High confidence
US 11,312,781Antigen Binding Molecules That Bind LIGHT
Lapsed Apr 26, 2026 on the fee record
Ended Apr 26, 2026 · High confidence
Centessa Pharmaceuticals (UK) LimitedLapsed Apr 26, 2026 on the fee recordEnded Apr 26, 2026
High confidence
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Capella Bioscience Ltd..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited